382 related articles for article (PubMed ID: 9312189)
1. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
Vachon PH; Xu H; Liu L; Loechel F; Hayashi Y; Arahata K; Reed JC; Wewer UM; Engvall E
J Clin Invest; 1997 Oct; 100(7):1870-81. PubMed ID: 9312189
[TBL] [Abstract][Full Text] [Related]
2. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
[TBL] [Abstract][Full Text] [Related]
3. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival.
Vachon PH; Loechel F; Xu H; Wewer UM; Engvall E
J Cell Biol; 1996 Sep; 134(6):1483-97. PubMed ID: 8830776
[TBL] [Abstract][Full Text] [Related]
4. Laminin-alpha2 (merosin), beta-dystroglycan, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study.
ter Laak HJ; Leyten QH; Gabreëls FJ; Kuppen H; Renier WO; Sengers RC
Clin Neurol Neurosurg; 1998 Mar; 100(1):5-10. PubMed ID: 9637197
[TBL] [Abstract][Full Text] [Related]
5. Merosin-integrin promotion of skeletal myofiber cell survival: Differentiation state-distinct involvement of p60Fyn tyrosine kinase and p38alpha stress-activated MAP kinase.
Laprise P; Poirier EM; Vézina A; Rivard N; Vachon PH
J Cell Physiol; 2002 Apr; 191(1):69-81. PubMed ID: 11920683
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin.
Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K
Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600
[TBL] [Abstract][Full Text] [Related]
7. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
Kuang W; Xu H; Vachon PH; Liu L; Loechel F; Wewer UM; Engvall E
J Clin Invest; 1998 Aug; 102(4):844-52. PubMed ID: 9710454
[TBL] [Abstract][Full Text] [Related]
8. β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.
Liu J; Milner DJ; Boppart MD; Ross RS; Kaufman SJ
Hum Mol Genet; 2012 Apr; 21(7):1592-603. PubMed ID: 22180459
[TBL] [Abstract][Full Text] [Related]
9. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
10. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
Gawlik KI; Holmberg J; Durbeej M
Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
[TBL] [Abstract][Full Text] [Related]
11. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability.
Mendell JR; Sahenk Z; Prior TW
J Child Neurol; 1995 Mar; 10(2):150-9. PubMed ID: 7782608
[TBL] [Abstract][Full Text] [Related]
12. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse.
Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T
Neuromuscul Disord; 1997 Jan; 7(1):7-12. PubMed ID: 9132144
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies.
Hodges BL; Hayashi YK; Nonaka I; Wang W; Arahata K; Kaufman SJ
J Cell Sci; 1997 Nov; 110 ( Pt 22)():2873-81. PubMed ID: 9427295
[TBL] [Abstract][Full Text] [Related]
15. Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.
Gawlik KI; Mayer U; Blomberg K; Sonnenberg A; Ekblom P; Durbeej M
FEBS Lett; 2006 Mar; 580(7):1759-65. PubMed ID: 16504180
[TBL] [Abstract][Full Text] [Related]
16. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.
Shibuya S; Wakayama Y; Inoue M; Kojima H; Oniki H
Med Electron Microsc; 2003 Dec; 36(4):213-20. PubMed ID: 16228654
[TBL] [Abstract][Full Text] [Related]
17. Confocal analysis of the dystrophin protein complex in muscular dystrophy.
Draviam R; Billington L; Senchak A; Hoffman EP; Watkins SC
Muscle Nerve; 2001 Feb; 24(2):262-72. PubMed ID: 11180210
[TBL] [Abstract][Full Text] [Related]
18. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
Voit T; Sewry CA; Meyer K; Hermann R; Straub V; Muntoni F; Kahn T; Unsöld R; Helliwell TR; Appleton R
Neuropediatrics; 1995 Jun; 26(3):148-55. PubMed ID: 7477753
[TBL] [Abstract][Full Text] [Related]
19. [Significance of merosin and sarcoglycan in manifestations of certain forms of muscular dystrophy].
Medić S; Rakocević-Stojanović V
Srp Arh Celok Lek; 1998; 126(1-2):34-9. PubMed ID: 9525081
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of laminin beta 1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy.
Li M; Dickson DW; Spiro AJ
Arch Neurol; 1997 Dec; 54(12):1457-61. PubMed ID: 9400354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
